Patents Assigned to Teon Therapeutics, Inc.
  • Cannabinoid receptor type 2 (CB2) modulators and uses thereof
    Patent number: 11957689
    Abstract: Disclosed herein are compounds, compositions, and methods for modulating the Cannabinoid receptor 2 (CB2) with the compounds and compositions disclosed herein. Also described are methods of treating diseases or conditions that are mediated by the action of Cannabinoid receptor 2 (CB2) or that we benefit from modulating the Cannabinoid receptor 2 (CB2).
    Type: Grant
    Filed: October 5, 2022
    Date of Patent: April 16, 2024
    Assignee: Teon Therapeutics, Inc.
    Inventors: Elfatih Elzein, Jiwen Liu
  • Cannabinoid receptor type 2 (CB2) modulators and uses thereof
    Patent number: 11564928
    Abstract: Disclosed herein are compounds, compositions, and methods for modulating the Cannabinoid receptor 2 (CB2) with the compounds and compositions disclosed herein. Also described are methods of treating diseases or conditions that are mediated by the action of Cannabinoid receptor 2 (CB2) or that we benefit from modulating the Cannabinoid receptor 2 (CB2).
    Type: Grant
    Filed: March 10, 2022
    Date of Patent: January 31, 2023
    Assignee: Teon Therapeutics, Inc.
    Inventors: Elfatih Elzein, Jiwen Liu
  • Adenosine receptor antagonists and uses thereof
    Patent number: 11124515
    Abstract: Disclosed herein are compounds of Formula (III), compositions and formulations thereof, and methods for modulating the A22B adenosine receptor for treatment of A2B adenosine receptor mediated diseases or conditions.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: September 21, 2021
    Assignee: Teon Therapeutics, Inc.
    Inventors: Jiwen Liu, Elfatih Elzein